Please assess the completion status of the following clinical trial:

Trial Title: Lidocaine-Ketamine Versus Ketamine for Induction of Anesthesia in Septic Shock Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients aged above 18 years~* With septic shock~* Scheduled for general anesthesia~Exclusion Criteria:~* Patients under 18 years~* Burn patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ketamine group (Type: ACTIVE_COMPARATOR): This group will receive induction of anesthesia using ketamie full dose 1 mg/kg, midazolam 0.05 mg/Kg, and normal saline 10 mL.
- Lidocaine-ketamine group (Type: EXPERIMENTAL): This group will receive induction of anesthesia using Ketamie half dose 0.5 mg/kg, midazolam 0.05 mg/Kg, and lidocaine 1 mg/Kg.

Based on this trial design, predict the completion outcome and termination type (if applicable).